Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

Similar articles for PubMed (Select 12651270)

1.

CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.

Carreras E, Saiz A, Marín P, Martínez C, Rovira M, Villamor N, Aymerich M, Lozano M, Fernández-Avilés F, Urbano-Izpizua A, Montserrat E, Graus F.

Haematologica. 2003 Mar;88(3):306-14.

2.

Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome.

Karam C, Klein CJ, Dispenzieri A, Dyck PJ, Mandrekar J, D'Souza A, Mauermann ML.

Neurology. 2015 May 12;84(19):1981-7. doi: 10.1212/WNL.0000000000001565. Epub 2015 Apr 15.

PMID:
25878176
3.

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.

Shevchenko JL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kurbatova KA, Gorodokin GI, Novik AA.

Ann Hematol. 2015 Jul;94(7):1149-57. doi: 10.1007/s00277-015-2337-8. Epub 2015 Feb 25.

PMID:
25711670
4.

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.

Le Page E, Deburghgraeve V, Lester MA, Cardiet I, Leray E, Edan G.

J Neurol. 2015 Apr;262(4):1024-34. doi: 10.1007/s00415-015-7653-3. Epub 2015 Feb 21.

PMID:
25701008
5.

Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.

Curro' D, Vuolo L, Gualandi F, Bacigalupo A, Roccatagliata L, Capello E, Uccelli A, Saccardi R, Sormani MP, Mancardi G.

Mult Scler. 2015 Jan 12. pii: 1352458514564484. [Epub ahead of print]

PMID:
25583838
6.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

PMID:
25546364
7.

[Autologous peripheral blood CD34+ stem cells transplanted into 100 patients with advanced cirrhosis].

Yao Y, Luo L, Xue H, Luo L, Zou H, Wang G, An Z, Zhong M, Huang X, Zhu Y, Wei L, Yang M, Zhang T, Xie P, Xu G, Deng S, Huang X.

Zhonghua Gan Zang Bing Za Zhi. 2014 Sep;22(9):667-70. doi: 10.3760/cma.j.issn.1007-3418.2014.09.007. Chinese.

PMID:
25369250
8.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.

Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.

Mult Scler. 2015 Feb;21(2):189-97. doi: 10.1177/1352458514541978. Epub 2014 Jul 30.

PMID:
25078274
9.

ANCA-positive vasculitis as a secondary autoimmune disease after autologous stem cell transplantation for systemic sclerosis: a case report.

Schmalzing M, Amann K, Tony HP.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-222-4. Epub 2014 Jul 8.

PMID:
25005330
10.

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis.

Snowden JA, Ansari A, Sachchithanantham S, Jackson G, Thompson N, Lobo A, Sanderson J, Kazmi M.

QJM. 2014 Nov;107(11):871-7. doi: 10.1093/qjmed/hcu095. Epub 2014 May 5.

PMID:
24803477
11.

Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study.

Khatri BO, Wroblewski M, Kramer J, Dukic M, Poplar A, Anderson AJ.

Curr Ther Res Clin Exp. 2006 Jan;67(1):55-65. doi: 10.1016/j.curtheres.2006.02.004.

12.

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19.

PMID:
24554104
13.
14.

An observational study of autologous bone marrow-derived stem cells transplantation in seven patients with nervous system diseases: a 2-year follow-up.

Ren C, Geng RL, Ge W, Liu XY, Chen H, Wan MR, Geng DQ.

Cell Biochem Biophys. 2014 May;69(1):179-87. doi: 10.1007/s12013-013-9756-8.

PMID:
24062130
15.

Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up.

Szabó GV, Kövesd Z, Cserepes J, Daróczy J, Belkin M, Acsády G.

Cytotherapy. 2013 Oct;15(10):1245-52. doi: 10.1016/j.jcyt.2013.05.017.

PMID:
23993298
16.

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.

Rivera VM, Jeffery DR, Weinstock-Guttman B, Bock D, Dangond F.

BMC Neurol. 2013 Jul 11;13:80. doi: 10.1186/1471-2377-13-80.

17.

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.

Pfender N, Saccardi R, Martin R.

Curr Treat Options Neurol. 2013 Jun;15(3):270-80. doi: 10.1007/s11940-013-0234-9.

PMID:
23637027
18.

An observational study of venoplasty in patients with multiple sclerosis.

Pryse-Phillips W, Stefanelli M, Murphy-Peddle K, Barrett B.

Can J Neurol Sci. 2013 Mar;40(2):203-9.

PMID:
23419569
19.

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.

Alchi B, Jayne D, Labopin M, Demin A, Sergeevicheva V, Alexander T, Gualandi F, Gruhn B, Ouyang J, Rzepecki P, Held G, Sampol A, Voswinkel J, Ljungman P, Fassas A, Badoglio M, Saccardi R, Farge D; EBMT Autoimmune Disease Working Party members.

Lupus. 2013 Mar;22(3):245-53. doi: 10.1177/0961203312470729. Epub 2012 Dec 20. Erratum in: Lupus. 2013 May;22(6):653. Demin, Alexander [added]; Kotova, O [removed].

PMID:
23257404
20.

Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.

Bonab MM, Sahraian MA, Aghsaie A, Karvigh SA, Hosseinian SM, Nikbin B, Lotfi J, Khorramnia S, Motamed MR, Togha M, Harirchian MH, Moghadam NB, Alikhani K, Yadegari S, Jafarian S, Gheini MR.

Curr Stem Cell Res Ther. 2012 Nov;7(6):407-14.

PMID:
23061813
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk